Liquidia 股价今天为何大涨？

Image 1: Plus500

Plus500

4.9

★★★★★

Open Account

Read Review

eToro

4.8

★★★★★

Open Account

Read Review

Tools

Calendars * Economic Calendar * Holiday Calendar * Earnings Calendar * Dividend Calendar * Splits Calendar * IPO Calendar * Futures Expiry Calendar

Investment Tools

*   [Stock Screener](https://www.investing.com/stock-screener)
*   [Fed Rate Monitor Tool](https://www.investing.com/central-banks/fed-rate-monitor)
*   [Currency Converter](https://www.investing.com/currency-converter/)
*   [Fibonacci Calculator](https://www.investing.com/tools/fibonacci-calculator)

Why is Liquidia stock surging today?

EditorVahid Karaahmetovic

Stock Markets

EditorVahid Karaahmetovic

Published Oct 14, 2026, 05:02 AM

Why is Liquidia stock surging today?

View all comments (0)0

Why is Liquidia stock surging today?

View all comments (0)0

Image 3: © Reuters.

In this article:

UTHR-1.22%

LQDA-3.11%

Investing.com -- Liquidia Corporation stock surged 46.7% in pre-open trading after the company announced a sweeping global settlement with United Therapeutics Corporation that resolves all six ongoing lawsuits between the two biopharmaceutical rivals for a net payment of $380.7 million, eliminating the existential legal risk that had weighed on the stock for weeks.

The deal, announced Tuesday evening after the regular session closed, ensures that YUTREPIA — Liquidia’s inhaled treprostinil powder approved for pulmonary arterial hypertension — remains on the market without disruption, removing what investors had feared could be a forced withdrawal of the company’s flagship commercial product.

The settlement follows a September 30 ruling by the U.S. District Court for the District of Delaware that found key claims of a United Therapeutics patent valid and infringed by Liquidia, a decision that had sent shares plunging nearly 57% in a single session and prompted multiple analyst downgrades from Wells Fargo, BTIG, and Raymond James.

As part of the agreement, Liquidia will not appeal the ruling and has submitted a label supplement removing the pulmonary hypertension associated with interstitial lung disease (PH-ILD) indication from YUTREPIA, while retaining the core PAH indication.

CFO and COO Michael Kaseta stated, "We expect to fund the outlined payments from the ongoing sales of YUTREPIA and cash on hand," a statement underpinned by preliminary Q3 2026 YUTREPIA net product sales of $222.7 million and cash reserves of $396.1 million as of September 30, 2026.

UTHR-1.22%LQDA-3.11%

United Therapeutics

Analyze UTHR

Included in our AI-picked strategies

Review strategies

543.40

▼-6.70(-1.22%)

Closed·13/10·USD

506.31

▼-37.09(-6.83%)

Pre Market·08:00:03

Max

In this article

UTHR-1.22%LQDA-3.11%

Trade

Analyze UTHR

Trade

A meaningful short interest position — representing roughly 15.6% of the float — likely amplified the upward move as short sellers rushed to cover positions.

The broader market provided virtually no tailwind on the day, with the S&P 500 edging up just 0.2%, the Dow Jones adding 0.3%, and the Nasdaq Composite essentially flat at +0.01%, confirming that the LQDA rally was driven entirely by company-specific developments rather than any macro or sector-wide catalyst.

Liquidia’s direct competitor United Therapeutics, whose Tyvaso franchise competes in the same PAH space, was not a source of sympathy-move dynamics on this occasion.

Taken together, the resolution of a multi-front legal battle that had erased more than half the stock’s value in a single day, combined with management’s credible plan to self-fund the settlement payments and the preservation of YUTREPIA’s core commercial franchise, gave investors a clear reason to aggressively re-rate the stock higher in pre-market trading today.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Where's the stop-loss on UTHR?

Most traders can read a chart. The hard part is committing: the entry window is open, the pattern is forming, and you're still waiting for confirmation.

Our Vision AI literally sees your UTHR chart and returns a complete trade plan — entry, stop-loss, and profit target — in under 60 seconds.

Stop guessing where the stop goes.

Flash Sale - 55% Off InvestingPro

Why is Liquidia stock surging today?

View all comments (0)0

Latest comments

Post

Comment Guidelines

Loading next article…

Trade With A Regulated Broker

Indices Commodities Bonds Stocks

Max

US 30

51,894.70

+223.7

+0.43%

US 500

7,821.90

+16.3

+0.21%

Dow Jones

51,670.10

-180.45

-0.35%

S&P 500

7,805.45

-1.79

-0.02%

Nasdaq

27,204.38

-41.52

-0.15%

S&P 500 VIX

15.22

-0.05

-0.33%

Dollar Index

102.018

+0.039

+0.04%

Crude Oil WTI Futures

94.56

+0.42

+0.45%

Brent Oil Futures

105.79

+0.10

+0.09%

Natural Gas Futures

3.303

+0.020

+0.61%

Gold Futures

4,164.30

-13.00

-0.31%

Silver Futures

58.695

-0.830

-1.39%

Copper Futures

6.7375

+0.0115

+0.17%

US Soybeans Futures

1,290.25

+6.25

+0.49%

U.S. 10Y

5.195

-0.022

-0.42%

U.S. 30Y

5.542

-0.021

-0.38%

U.S. 5Y

4.985

-0.022

-0.44%

U.S. 3M

4.203

+0.021

+0.50%

US 10Y T-Note Futures

104.88

+0.14

+0.13%

Euro Bund Futures

121.17

+0.11

+0.09%

10-2 Yield Spread

31.32

+4.15

+15.27%

AAPL

341.27

+0.30

+0.09%

NVDA

228.52

+2.20

+0.97%

GOOGL

353.78

+1.06

+0.30%

TSLA

375.23

-2.80

-0.74%

AMZN

258.58

-0.95

-0.37%

NFLX

70.46

-0.15

-0.21%

Name	Last	Chg. %	Vol.
CDW	151.97	+5.71%	2.50M
VLO	456.46	+4.69%	2.52M
CHTR	106.95	+4.36%	3.10M
ORCL	143.20	+4.23%	26.33M
PSX	292.73	+4.00%	2.61M
MPC	476.98	+3.96%	1.65M
FSLR	186.60	+3.83%	2.42M

Name	Last	Chg. %	Vol.
AMAT	464.24	-6.69%	10.88M
JNJ	248.61	-5.73%	16.65M
C	124.53	-5.60%	20.44M
DPZ	296.10	-4.76%	2.06M
KKR	87.16	-4.75%	9.22M
VRTX	485.22	-4.30%	1.19M
SPCX	156.54	-4.21%	69.02M

Trending Stocks

Name	Last	Chg. %	Vol.
MU	953.19	-3.62%	29.23M
JPM	331.43	-0.86%	13.76M
SNDK	1,482.33	-0.34%	8.40M
NVDA	228.52	+0.97%	84.04M
SPCX	156.54	-4.21%	69.02M

ProPicks AI

AI-powered stock picks with a proven track record to beat the S&P 500.

Tech Titans

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Top Value Stocks

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Best of Buffett

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Energy Elite

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Financial Fortresses

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Quality Compounders

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Small-Cap Sprinters

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Healthcare Heroes

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Beat the S&P 500

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Dominate the Dow

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Mid-Cap Movers

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Mexican Stock Exchange Leaders

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Best Brazilian Stocks

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Italian Market Elite

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Alpha Germany Select

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Comments

Post

Comment Guidelines

Calendars

Economic Calendar Earnings Calendar Holiday Calendar

US Economy

Fed Rate Monitor Tool US Treasury Yield Curve

More Tools

Stock Screener Currency Converter

Markets Ask WarrenAI Stocks Picked by AI Watchlist Alerts Top Brokers Breaking News Tools

Install Our App Scan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Mediawould like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.Fusion Mediaand any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

By using this site, you agree with our use of cookies. Please see our privacy statement for more information.

Liquidia 股价今天为何大涨？

Popular Searches

Please try another search

Top Brokers

Why is Liquidia stock surging today?

Where's the stop-loss on UTHR?

Latest comments

Trending Stocks